Publication: 263

Publication: 263

Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials.

PubMed

DOI

Google Scholar

Citation:: J Clin Oncol vol 26 (4) 527-34

Year:: 2008
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Experimental
Sec. Committees:

Pharmas:
Grants:: UL1 TR000005

Corr. Author:
Authors:: Edward L Korn Ping-Yu Liu Sandra J Lee Judith-Anne W Chapman Donna Niedzwiecki Vera J Suman James Moon Vernon K Sondak Michael B Atkins Elizabeth A Eisenhauer Wendy Parulekar Svetomir N Markovic Scott Saxman John M Kirkwood

Networks:

Study: NCCTG-N9975
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: Benchmarking, Brain Neoplasms, Clinical Trials, Phase II as Topic, Disease-Free Survival, Humans, Melanoma, Meta-Analysis as Topic, Multivariate Analysis, Prognosis, Research Design, Sample Size, Skin Neoplasms, Survival Analysis, Survival Rate